Back to search

Article

Lymphocyte subsets and inflammatory factors as predictors of immunotherapy efficacy in patients with hepatocellular carcinoma

2023-09-25

Abstract excerpt

<h4>Objective: </h4> ：We aimed to investigate the correlation between lymphocyte subpopulations expressing inhibitor receptors, IL-6 levels, and the efficacy of immunotherapy in patients with hepatocellular carcinoma. <h4>Methods: </h4>： Blood samples were prospectively collected before and after immunotherapy from patients with intermediate and advanced hepatocellular carcinoma who were treated with immunotherapy...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
88d64196-6dca-5bc5-886d-47d6b40d2d04
DOI
10.21203/rs.3.rs-3353697/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Lymphocyte subsets and inflammatory factors as predictors of immunotherapy efficacy in patients with hepatocellular carcinomaDOI 10.21203/rs.3.rs-3353697/v1
Prognostic value of the ratio of Interleukin-2 and Interleukin-10 in patients with hepatocellular carcinoma treated with anti-PD-1 therapySemantic proximity
Comprehensive Analysis of Immune Infiltration Identifies Predictors for Immunotherapy Efficacy in Hepatocellular CarcinomaSemantic proximity
Immune Cell Composition of Liver Hepatocellular Carcinoma and its clinical relevance: A research based on TCGA databaseSemantic proximity
Construction and evaluation of clinical prediction model for immunotherapy-related adverse events and clinical benefit in cancer patients receiving immune checkpoint inhibitors based on serum cytokine levelsSemantic proximity
Characterization of positively regulate T cell proliferation-related genes in hepatocellular cancer to guide clinical therapySemantic proximity
Characteristics and Hematological Indicators Predictors of Immunotherapy Response in Advanced Non-Small Cell Lung CancerSemantic proximity
Pretreatment platelet-to-lymphocyte ratio (PLR) as a prognosticating indicator for gastric cancer patients receiving immunotherapySemantic proximity
Immune repertoire: A potential biomarker and therapeutic for hepatocellular carcinoma.Semantic proximity
Effects of anlotinib combined with second-line chemotherapy on the levels of immune cells and inflammatory factors and the curative effects in patients with advanced non-small cell lung cancerSemantic proximity
Pretreatment Platelet-to-Lymphocyte Ratio (PLR) is associated with prognosis in gastric cancer patients with immunotherapySemantic proximity
Prognostic Value of the Ratio of Interleukin-2 and Interleukin-10 in Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Therapy.Semantic proximity
Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular CarcinomaSemantic proximity
Select a neighboring publication to make it the new centre.